Contrast performance best with zero spherical aberrations

Article

By using adaptive optics and physiological eye models, Pablo Artal and colleagues from Universidad de Murcia, Spain have determined that contrast performance peaks when spherical aberration is completely corrected.

By using adaptive optics and physiological eye models, Pablo Artal and colleagues from Universidad de Murcia, Spain have determined that contrast performance peaks when spherical aberration is completely corrected.

An adaptive-optics based vision simulator that allowed for simultaneous manipulation of ocular wavefront aberration and measurement of visual performance was created. The simulator consisted of a wavefront sensor, an adaptive optics mirror and a visual testing path. Subjective measurements of contrast sensitivity in five subjects with different levels of naturally occurring spherical aberration, at 15 c/deg with a 4.8 mm pupil, were performed.

Contrast sensitivity was measured for spherical aberration values of -0.09, 0.0, 0.09 and 0.182 µm with the other naturally occurring aberrations of the eye present and corrected and with defocus varying from +0.5 to -0.5 D. The same levels of spherical aberration were compared in physiological eye models to establish tolerances to tilt and decentration and to verify through-focus performance.

Each subject experienced peak contrast sensitivity performance with varying levels of spherical aberration when their natural aberrations were present, however, the average contrast performance peaked with 0 µm of spherical aberration.

The researchers concluded that contrast performance is at its best when spherical aberration is completely corrected.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.